Johnson & Johnson share price logo

Johnson & Johnson

NASDAQ: JNJ

Mega Cap

$228.39

-5.81

(-2.48%)

as on

Johnson & Johnson Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $227.60
    $232.75
    downward going graph

    0.35%

    Downside

    1.91%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $149.04
    $251.71
    downward going graph

    34.74%

    Downside

    10.21%

    Upside

    downward going graph

Johnson & Johnson share price movements today

Previous Close
$234.20
Open
$231.58
Volume
6.2M
Day's Low - High
$227.60 - $232.75
52 Week Low - High
$149.04 - $251.71

Johnson & Johnson Historical Returns

1 Month Return
-0.7 %
3 Month Return
-3.88 %
1 Year Return
+ 51.52 %
3 Year Return
+ 39.07 %
5 Year Return
+ 41 %

Johnson & Johnson Stock Fundamentals & Key Indicators

Check Johnson & Johnson market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$563.8B

EPS (TTM)

11.5743

Dividend Yield

2.21%

Quarterly Earnings Growth YOY

-0.53%

PE Ratio (TTM)

27.14

Industry PE ratio

24.841428571428573

PEG Ratio

3.0439

EBITDA

34.3B

Revenue (TTM)

96.4B

Profit Margin

21.83%

Return On Equity TTM

26.42%

Johnson & Johnson Stock Valuation

Track how Johnson & Johnson P/E has moved over time to understand its valuation trends.

Johnson & Johnson in the last 5 years

  • Overview

  • Trends

Lowest (13.06x)

June 30, 2025

Industry (24.84x)

June 19, 2026

Today (27.14x)

June 19, 2026

Highest (22.90x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 27.14x

Johnson & Johnson vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Johnson & Johnson with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Johnson & Johnson image
Johnson & Johnson
BUY$563.8B41%27.1421.83%2.21%
Procter & Gamble Company image
Procter & Gamble Company
BUY$350.6B13.9%21.9819.16%2.77%
Pfizer Inc. image
Pfizer Inc.
HOLD$147.7B-35.04%19.7911.83%6.61%

Stock Returns calculator for Johnson & Johnson Stock including INR - Dollar returns

The Johnson & Johnson stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Johnson & Johnson investment value today

Current value as on today

₹1,65,360

Returns

₹65,360

(+65.36%)

Returns from Johnson & Johnson Stock

₹51,523 (+51.52%)

Dollar Impact

₹13,837 (+13.84%)

Analyst Recommendation on Johnson & Johnson Stock

Based on 28 analysts

BUY

53.57%

Buy

46.43%

Hold

0.00%

Sell

Based on 28 analysts, 53.57% of analysts recommend a 'BUY' rating for Johnson & Johnson. Average target price of $252.87

Johnson & Johnson Share Price Target

Get share price movements and forecasts by analysts on Johnson & Johnson.

What analysts predicted

9.68%UPSIDE

Target Price

$252.87

Current Price

$228.39

Analyzed by

28 Analysts

Target

$252.87

Johnson & Johnson target price $252.87, a slight upside of 9.68% compared to current price of $228.39. According to 28 analysts rating.

Indian Investors' Interest in Johnson & Johnson Stock

Investment in Johnson & Johnson Shares on INDmoney has grown by 3.21% in the last 30 days, indicating increased investment activity.

Time period: to

Change:3.21% versus previous 30 day period

Search interest for Johnson & Johnson Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:39% versus previous 30 day period

Johnson & Johnson Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
21,395
21,383
22,447
22,471
22,520
21,893
23,743
23,993
24,564
24,062
Gross Profit
14,597
14,872
15,578
15,508
15,392
14,536
16,115
16,690
16,596
17,203
Operating Income
4,607
6,273
6,657
5,278
3,841
6,299
6,810
7,096
5,591
6,395
EBITDA
6,820
5,684
7,800
5,377
5,920
15,607
8,742
9,288
7,191
8,266
Interest Expense
151
155
270
193
137
204
308
245
214
272
Depreciation
1,843
1,815
1,782
1,846
1,896
1,772
1,943
1,777
2,011
2,004
Income Before Tax
4,826
3,714
5,748
3,338
3,887
13,631
6,491
7,493
4,966
5,990
Income Tax Expense
694
459
1,062
644
456
2,632
954
2,341
-150
755
Net Income
4,049
3,255
4,686
2,694
3,431
10,999
5,537
5,152
5,116
5,235
Net Profit Margin
18.92%
15.22%
20.88%
11.99%
15.24%
50.24%
23.32%
21.47%
20.83%
21.76%

Johnson & Johnson Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
71,890
76,450
81,581
82,059
82,584
78,740
79,990
85,159
88,821
94,193
Gross Profit
50,101
51,011
54,490
54,503
54,157
55,338
55,394
58,413
61,350
68,558
Operating Income
20,891
18,897
21,175
20,970
19,733
20,943
21,013
21,853
22,149
25,596
EBITDA
24,283
24,249
25,933
24,655
23,929
26,751
26,605
29,339
24,781
41,055
Interest Expense
726
934
1,005
318
201
183
276
1,247
755
971
Depreciation
-
5,642
6,929
7,009
7,231
7,390
6,970
7,486
7,339
7,503
Income Before Tax
19,803
17,673
17,999
17,328
16,497
19,178
19,359
15,062
16,687
32,581
Income Tax Expense
3,263
16,373
2,702
2,209
1,783
1,377
2,989
1,736
2,621
5,777
Net Income
16,540
1,300
15,297
15,119
14,714
20,878
17,941
35,153
14,066
26,804
Net Profit Margin
23.01%
1.70%
18.75%
18.42%
17.82%
26.52%
22.43%
41.28%
15.84%
28.46%

Johnson & Johnson Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
3,255
4,686
2,694
3,431
10,999
5,537
5,152
5,116
5,235
Operating Cash Flow
3,657
5,633
7,993
6,983
4,174
3,878
9,169
7,309
2,514
Investing Cash Flow
-464
-13,687
-3,128
-1,320
-297
-18,264
-542
-4,485
-1,040
Financing Cash Flow
546
7,544
-9,882
-1,340
10,422
-5,665
-8,927
-1,369
530
Change in Cash
3,614
-595
-4,898
4,125
14,369
-19,897
-346
1,478
1,979

Johnson & Johnson Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
1,300
15,297
15,119
14,714
20,878
17,941
35,153
14,066
26,804
Operating Cash Flow
21,056
22,201
23,416
23,536
23,410
21,194
22,791
24,266
24,530
Investing Cash Flow
-14,868
-3,167
-6,194
-20,825
-8,683
-12,371
878
-18,599
-23,588
Financing Cash Flow
-7,673
-18,510
-18,015
-6,120
-14,047
-8,871
-15,825
-3,132
-5,539
Change in Cash
-1,148
283
-802
-3,320
502
-360
7,732
2,246
-4,396

Mutual Funds that own Johnson & Johnson Stock

Check out the Mutual Funds with significant holdings in Johnson & Johnson.

Global Institutional Holdings in Johnson & Johnson

Funds
Holdings
The Goldman Sachs Group Inc
0.75%
Geode Capital Management, LLC
2.46%
Massachusetts Financial Services Company
0.68%
State Farm Mutual Automobile Ins Co
1.31%
Wellington Management Company LLP
0.83%
See all

Johnson & Johnson News & Key Events

  • img

    Today's Timeline - 17 June

    Thu, 01:45 AM

    -

    Johnson & Johnson reports Phase 3 results for TALVEY plus DARZALEX FASPRO, showing improved outcomes in multiple myeloma treatment.

    Thu, 06:46 AM

    -

    Johnson & Johnson announces over $1 billion investment in Jacksonville for contact lens manufacturing facility, operational by 2028.

Insights on Johnson & Johnson

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Johnson & Johnson has shown positive profit trends over the last two quarters. Their net profit increased from $5.11 billion to $5.23 billion, reflecting an average increase of 2.3% per quarter.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, JNJ has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, JNJ has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Johnson & Johnson's revenue has decreased for the last two quarters, falling from $24.56 billion to $24.06 billion. This represents an average decrease of 2.0% per quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, JNJ stock has moved down by -5.2%

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
OrganisationJohnson & Johnson
HeadquartersOne Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933
IndustryDrug Manufacturers - General
CEOMr. Joaquin Duato
E-voting on sharesClick here to vote

Key Management of Johnson & Johnson

Name

Title

Ms. Elizabeth Forminard J.D.

Executive VP & Chief Legal Officer

Mr. Joaquin Duato

CEO & Chairman

Ms. Jennifer L. Taubert

Executive VP & Worldwide Chairman of Innovative Medicine

Mr. Robert J. Decker Jr.

Controller & Chief Accounting Officer

Mr. James Swanson

Executive VP & Chief Information Officer

Dr. Guy J. Lebeau M.D.

Group Chairman of MD&D Business - EMEA

Dr. John C. Reed M.D., Ph.D.

Executive Vice President of Innovative Medicine and R&D

Mr. Timothy Schmid

Executive VP & Worldwide Chairman of MedTech

Mr. Dirk Brinckman

Chief Compliance Officer

Ms. Kristen Blair Mulholland

Executive VP & Chief Human Resources Officer

FAQs

What is Johnson & Johnson share price today?

Johnson & Johnson share price today is $228.39 as on at the close of the market. Johnson & Johnson share today touched a day high of $232.75 and a low of $227.6.

What is the 52 week high and 52 week low for Johnson & Johnson share?

Johnson & Johnson share touched a 52 week high of $251.71 on and a 52 week low of $149.04 on . Johnson & Johnson stock price today i.e. is closed at $228.39,which is 9.26% down from its 52 week high and 53.24% up from its 52 week low.

What is Johnson & Johnson's market capitalisation today?

Johnson & Johnson market capitalisation is $0.56T as on .

How to invest in Johnson & Johnson Stock (JNJ) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Johnson & Johnson on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Johnson & Johnson Shares that will get you 0.0066 shares as per Johnson & Johnson share price of $228.39 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Johnson & Johnson Stock (JNJ) from India?

Indian investors can start investing in Johnson & Johnson (JNJ) shares with as little as ₹94.323 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.23 in Johnson & Johnson stock (as per the Rupee-Dollar exchange rate as on ). Based on Johnson & Johnson share’s latest price of $228.39 as on June 19, 2026 at 8:45 am IST, you will get 0.0438 shares of Johnson & Johnson. Learn more about fractional shares .

What are the returns that Johnson & Johnson has given to Indian investors in the last 5 years?

Johnson & Johnson stock has given 41% share price returns and 27.79% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?